Clariness and SubjectWell merged to create one of the largest global, full-service patient recruitment providers on the planet. Despite the continuous innovation and global delivery of both companies, the industry continuously reports the need for more global capabilities, more therapeutic area expertise and advanced insights and reporting. That’s why ‘the new Clariness’ is built on the combined expertise, technologies, and patient communities of both, to fill the gaps that has previously held back global patient enrollment.
Enhanced global reach – Our combined global reach has been bolstered through the integration of SubjectWell’s US infrastructure and millions of patients within its community into Clariness’ more established EMEA and APAC enrollment ecosystem.
One enrollment ecosystem – We launched our Clariness Hub, which brings together the capabilities, data, performance metrics, and intelligent patient targeting across both companies into one single enrollment ecosystem.
Solutions for every enrollment challenge – Integrating the enrollment solutions behind the support of 2,500 global studies, we now offer a solutions across the three main enrollment areas of our clients, these are enrollment feasibility, patient recruitment, and engagement and retention.
Injecting a scientific approach to our enrollment strategies – We’ve integrated enrollment feasibility models that have been validated through peer-reviewed publications and industry research into our entire suite of solutions, to deliver even more accurate funnel and enrollment strategies.
Together, we bring sponsors and CROs unmatched reach across 60+ countries, 12,500+ research sites, 400+ indications, and one of the world’s largest patient communities, giving clients the true global partner they have been looking for until now.
We are fully committed to outcome-based pricing; however our patient recruitment models will be more balanced across three key areas: setup and systems, outreach and media, and performance delivery, with full transparency of investment against each stage of our statistically-backedenrollment funnel projections.
Clariness has offered performance-based commercial models long before the merger, this does not change. What has changed is our ability to more accurately forecast our outcome projections, thanks to a larger patient network, richer data, and scientifically validated enrollment feasibility models.
While the Clariness name and brand remains, we have taken a “”best of both”” approach; ClinLife is now one of three enrollment platforms that make the Clariness Hub, which is a true combination of the solutions, expertise and technologies of both companies, Clients who worked with either Clariness or SubjectWell previously, will only gain the benefits of enhanced solutions, more accurate funnels, higher patient quality, expanded global reach and more.
This is also reflected in our senior management team. Our leadership team is comprised of executives from both companies, led under the direction of Jim Corrigan, a new addition to Clariness who brings with him decades of experience in leading newly merged businesses to elevated success. Every department across the business is also equipped talent from both organizations in all our locations.
What sets Clariness apart: Most patient recruitment vendors do one thing well. They have reach, technology, or local expertise in a limited number of regions. Clariness now has all of it, at scale, in one place. Several points separate us from the rest of the market: a truly global footprint with compliant operations, a 15M patient community, unmatched experience and first-party data, with a performance track record of 80%+ of projects delivered in line with contracted promises.
Global reach with local intelligence: 60+ countries, 35+ languages, native-speaking in-market teams who understand cultural nuance. This is not just translation; it is genuine local execution backed by 20 years of building patient communities in markets that are genuinely hard to recruit in. Our international team speak enough languages to converse with >70% of the world’s population.
Recruitment technology built for outcomes, not optics: ClinLife® is the world’s leading patient portal with 15 million+ annual visitors and over 400 indications covered. Combined with SubjectWell’s science-backed models and partnerships with healthcare partners, clients get a platform that is designed to convert, not just attract.
Performance accountability: We do not just generate referrals and move on. Our Enrollment Enablement Team globally follows patients through the funnel, in their language, at the right time, using data to optimize contact timing and channel selection. That is why we can stand behind outcome-based pricing.
Science first: The new Clariness was built around scientific rigor, protocol feasibility, patient pre-screening, indication-specific expertise, and indication-specific recruitment models such as those for oncology. We treat recruitment as a clinical discipline, not a media spray and pray.
One partner, full lifecycle: From feasibility and study start-up through to enrollment, retention, and outcomes. Sponsors no longer need to manage multiple vendors across the enrollment journey. We cover it on a global scale, and accountable end to end.
The honest difference: Anyone can promise patients. We’ve delivered on more than 42,000 promises in the form of patient randomizations.
We deliberately do not lead with a fixed channel mix, because the right mix depends entirely on the indication, geography, patient population, and study design. A rare disease trial in Eastern Europe has a completely different optimal channel strategy to a Type 2 diabetes study in the US. Locking clients into a predefined media model is how recruitment vendors underdeliver.
Clariness operates one of the largest digital patient outreach networks in the industry, combining paid social including Meta and other platforms, search, display, patient communities, condition-specific portals, ClinLife® organic traffic, and partner networks. Meta is one of our key partners, but the portion Meta represents has been shrinking over recent years as we purposefully diversify our channel mix with many other partners. To give an example, we leverage an affiliate partner network of 100+ partners across 20+ countries. No single channel dominates because no single channel should. Our channel mix is indication- and geography-led, not platform-led. We use every channel that works for the patient population in question, optimized continuously through data, and we are transparent with clients on where their media investment is going and what it is returning.
Sites have competing priorities and different levels of resources, what we control is how actively we support them, how visible the referral pipeline is, and how quickly we spot a site falling behind, so we can intervene.
We maintain a consistent site opt-in rate of around 70-80%, and boast a site satisfaction score of 80%. We request that sites process referrals within 3-5 working days, and support this through our dedicated site support team and escalation processes. This keeps referrals moving and ensures our customers’ investments yield returns.
What clients should push us on: Ask for site activation timelines, average time from referral to first contact, and dropout rates between referral and screening visit by study. Those three numbers tell you more about funnel health than any headline metric we could quote, and they’re exactly what our site partnership team tracks daily, escalating any site that falls behind.
Tell us about your trial and a Clariness specialist will be in touch within one business day.
